Surinder K. Sharma - Concepedia

Author

Surinder K. Sharma

Also Known As

SURINDER K SHARMA, Sandeep Sharma, Sharma, Surinder Kumar, Surinder K Sharma, Surinder K. Sharma, Surinder Kumar Sharma, Surinder Sharma, SurinderKumar Sharma, Surinder K. Sharma

Publications

2.8K

Citations

H-Index

Concepts

All Affiliations

University College London The Royal Free Hospital Cancer Research UK Institute of Cancer Research Charing Cross Hospital

About

Surinder K. Sharma is an author at University College London specializing in medicine, engineering, and antibody engineering.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	12	586
2	Engineering	10	10	271
3	Natural Sciences	4	4	142
4	Public Health	3	3	58
5	Allergy	1	1	74

Surinder K. Sharma

Publications

1.6K

Citations

H-Index

Page 1

	Year	Citations
The clinical efficacy of first-generation carcinoembryonic antigen (CEACAM5)-specific CAR T cells is limited by poor persistence and transient pre-conditioning-dependent respiratory toxicity Fiona Thistlethwaite, David E. Gilham, Ryan D. Guest, Cancer Immunology Immunotherapy	2017	395
Ablation of human choriocarcinoma xenografts in nude mice by antibody-directed enzyme prodrug therapy (ADEPT) with three novel compounds Caroline J. Springer, Kenneth D. Bagshawe, Surinder K. Sharma, European Journal of Cancer and Clinical Oncology Novel CompoundsDrug TargetingNude MicePolymer-drug ConjugateMedicine	1991	116
A Phase I Study of Single Administration of Antibody-Directed Enzyme Prodrug Therapy with the Recombinant Anti–Carcinoembryonic Antigen Antibody-Enzyme Fusion Protein MFECP1 and a Bis-Iodo Phenol Mustard Prodrug Astrid Mayer, Roslyn J. Francis, Surinder K. Sharma, Clinical Cancer Research NanotherapeuticsProdrug ActivationImmunologyBiological TherapyImmunotherapeutics	2006	80
Antibody-directed enzyme prodrug therapy: pharmacokinetics and plasma levels of prodrug and drug in a phase I clinical trial Janet Martin, Stephen M. Stribbling, Grace K. Poon, Cancer Chemotherapy and Pharmacology Plasma LevelsMedicineImmunologyAntibody EngineeringPharmacotherapy	1997	79
Synthesis of bimetallic Pt–Cu nanoparticles and their application in the reduction of rhodamine B Henam Premananda Singh, Nikesh Gupta, Surinder K. Sharma, Colloids and Surfaces A Physicochemical and Engineering Aspects Materials ScienceChemical EngineeringRhodamine BEngineeringBimetallic Pt–cu Nanoparticles	2012	79
Sustained Tumor Regression of Human Colorectal Cancer Xenografts Using a Multifunctional Mannosylated Fusion Protein in Antibody-Directed Enzyme Prodrug Therapy Surinder K. Sharma, RB Pedley, Jeetendra Bhatia, Clinical Cancer Research	2005	77
A Phase I Trial of Radioimmunotherapy with 131I-A5B7 Anti-CEA Antibody in Combination with Combretastatin-A4-Phosphate in Advanced Gastrointestinal Carcinomas Tim Meyer, Andrew Gaya, Gairin Dancey, Clinical Cancer Research	2009	77
Human immune response to monoclonal antibody-enzyme conjugates in ADEPT pilot clinical trial Surinder K. Sharma, Kenneth D. Bagshawe, Roger G. Melton, Cell Biophysics Monoclonal Antibody-enzyme ConjugatesAutoimmune DiseaseAllergyImmunologyImmunodominance	1992	74
Clearance mechanism of a mannosylated antibody–enzyme fusion protein used in experimental cancer therapy Heide Kogelberg, Berend Tolner, Surinder K. Sharma, Glycobiology	2006	63
Efficacy & safety evaluation of Ayurvedic treatment (Ashwagandha powder & Sidh Makardhwaj) in rheumatoid arthritis patients: a pilot prospective study. YogendraKumar Gupta, Amita Srivastava, Surinder K. Sharma, The Indian Journal of Medical Research	2015	53

Page 1